The latest announcement is out from California Nanotechnologies ( ($TSE:CNO) ). California Nanotechnologies has entered into a strategic agreement ...

Dozens of people asked the Seattle School Board’s newest members about the future of Seattle Public Schools during a Dec. 8 ...

California Nanotechnologies Corp. (TSXV: CNO) (OTCID: CANOF) ("Cal Nano" or the "Company") is pleased to announce it has ...

Investing.com -- Kyverna Therapeutics (NASDAQ:KYTX) stock surged 14% Monday after the company announced positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel (miv-cel ...

As organizations increasingly look to AI systems to transform the workspace, People and Talent professionals are being ...

Kyverna shares Phase 2 data showing single-dose CAR-T improved mobility and reduced disability in stiff person syndrome.

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to ...

Bhubaneswar: Acting on a directive from the ministry of home affairs (MHA), Odisha police have instructed superintendents of police (SPs) to make exte.

Kyverna Therapeutics looks all the more likely to win the first FDA approval for a CAR-T therapy in an autoimmune disease after a registrational trial showed “highly statistically significant” ...

Kyverna Therapeutics (NASDAQ:KYTX) shares climbed 14% on Monday after the company reported encouraging topline outcomes from ...

Bhubaneswar: In a stark illustration of the escalating unemployment crisis in Odisha, more than 8,000 candidates turned up on ...

Miv-cel was reported to be well tolerated in the KYSA-8 trial. No high-grade cases of cytokine release syndrome or immune ...